These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9105227)

  • 1. A technique for population pharmacodynamic analysis of concentration-binary response data.
    Bailey JM; Gregg KM
    Anesthesiology; 1997 Apr; 86(4):825-35. PubMed ID: 9105227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of pharmacodynamic analysis by logistic regression: mixed-effects modeling.
    Lu W; Ramsay JG; Bailey JM
    Anesthesiology; 2003 Dec; 99(6):1255-62. PubMed ID: 14639136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of pharmacodynamic analysis by logistic regression: a computer simulation study.
    Lu W; Bailey JM
    Anesthesiology; 2000 Apr; 92(4):985-92. PubMed ID: 10754617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacodynamic Modeling Using the Sigmoid E
    Proost JH; Eleveld DJ; Struys MMRF
    AAPS J; 2020 Dec; 23(1):10. PubMed ID: 33367961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technique for quantifying the duration of intravenous anesthetic effect.
    Bailey JM
    Anesthesiology; 1995 Nov; 83(5):1095-103. PubMed ID: 7486161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.
    Millenbaugh NJ; Wientjes MG; Au JL
    Cancer Chemother Pharmacol; 2000; 45(4):265-72. PubMed ID: 10755313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane.
    Rehberg B; Bouillon T; Zinserling J; Hoeft A
    Anesthesiology; 1999 Aug; 91(2):397-405. PubMed ID: 10443602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacodynamics: strategies for concentration-and effect-controlled clinical trials.
    Ebling WF; Levy G
    Ann Pharmacother; 1996 Jan; 30(1):12-9. PubMed ID: 8773159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in and limitations of up-and-down methodology: a précis of clinical use, study design, and dose estimation in anesthesia research.
    Pace NL; Stylianou MP
    Anesthesiology; 2007 Jul; 107(1):144-52. PubMed ID: 17585226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies.
    Evans L; Aarons L; Brearley C
    J Pharm Pharmacol; 2005 Feb; 57(2):183-9. PubMed ID: 15720781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevoflurane remifentanil interaction: comparison of different response surface models.
    Heyse B; Proost JH; Schumacher PM; Bouillon TW; Vereecke HE; Eleveld DJ; Luginbühl M; Struys MM
    Anesthesiology; 2012 Feb; 116(2):311-23. PubMed ID: 22222473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A generalization of the probit and logit methods for dose response curves.
    Prentice RL
    Biometrics; 1976 Dec; 32(4):761-8. PubMed ID: 1009225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of age on propofol pharmacodynamics.
    Schnider TW; Minto CF; Shafer SL; Gambus PL; Andresen C; Goodale DB; Youngs EJ
    Anesthesiology; 1999 Jun; 90(6):1502-16. PubMed ID: 10360845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing lethal dose ratios using probit regression with arbitrary slopes.
    Lei C; Sun X
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):61. PubMed ID: 30290834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacodynamic interaction between propofol and remifentanil on the tolerance response to electrical tetanus stimuli].
    Yang L; Wei B; Zhang LP; Bi SS; Lu W; Guo XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):547-53. PubMed ID: 20957013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic interaction models in pediatric anesthesia.
    Hannam JA; Anderson BJ
    Paediatr Anaesth; 2015 Oct; 25(10):970-80. PubMed ID: 26240956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic modeling of muscle relaxants: effect of design issues on results.
    Paul M; Fisher DM
    Anesthesiology; 2002 Mar; 96(3):711-7. PubMed ID: 11873049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response surface model for anesthetic drug interactions.
    Minto CF; Schnider TW; Short TG; Gregg KM; Gentilini A; Shafer SL
    Anesthesiology; 2000 Jun; 92(6):1603-16. PubMed ID: 10839909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.